The challenge of an expanded therapeutic window in pulmonary hypertension
Our understanding of the causes and consequences of pulmonary hypertension is limited. Consequently, its most distinctive forms with the worst prognosis have been the focus for diagnosis and treatment. We highlight the emerging challenge of reframing the prevalence and prognostic implications of pulmonary hypertension, focusing on the optimal therapeutic window to address the high mortality linked to this condition.
Innovative health programs to reduce inequality in heart disease
National Health and Medical Research CouncilFind out more...